The tolerability issue of generic imatinib in patients with chronic myeloid leukemia (Comment on Adi J. Klil-Drori et al., Haematologica 2019;104(7):e293)

Lignende værker

• Radotinib in the treatment of chronic phase chronic myeloid leukemia patients
  af: Eskazan, Ahmet Emre, et al.
  Udgivet: (2015)
• Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia
  af: Eşkazan, Ahmet Emre, et al.
  Udgivet: (2013)
• IGHV1 status in chronic lymphocytic leukemia identify ethnic groups with an aggressive clinical course (Comment to Giudice ID, Foà R. Haematologica. 2019;104(2):219-221)
  af: Amato, Teresa, et al.
  Udgivet: (2019)
• Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy
  af: Eskazan, Ahmet Emre, et al.
  Udgivet: (2011)
• Interstitial Pneumonitis in a Patient with Chronic Myeloid Leukemia
  af: Eşkazan, Ahmet Emre, et al.
  Udgivet: (2013)